Inari Medical Inc (NARI)
49.66
-0.09
(-0.18%)
USD |
NASDAQ |
Nov 22, 16:00
49.63
-0.03
(-0.06%)
After-Hours: 20:00
Inari Medical Research and Development Expense (Quarterly): 29.43M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 29.43M |
| June 30, 2024 | 24.90M |
| March 31, 2024 | 26.88M |
| December 31, 2023 | 22.89M |
| September 30, 2023 | 21.49M |
| June 30, 2023 | 21.08M |
| March 31, 2023 | 22.06M |
| December 31, 2022 | 20.41M |
| September 30, 2022 | 19.10M |
| June 30, 2022 | 18.57M |
| March 31, 2022 | 16.14M |
| December 31, 2021 | 18.73M |
| Date | Value |
|---|---|
| September 30, 2021 | 12.50M |
| June 30, 2021 | 11.63M |
| March 31, 2021 | 8.163M |
| December 31, 2020 | 6.536M |
| September 30, 2020 | 5.217M |
| June 30, 2020 | 3.628M |
| March 31, 2020 | 3.018M |
| December 31, 2019 | 2.709M |
| September 30, 2019 | 1.722M |
| June 30, 2019 | 1.58M |
| March 31, 2019 | 1.209M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.709M
Minimum
Dec 2019
29.43M
Maximum
Sep 2024
15.75M
Average
18.65M
Median
Research and Development Expense (Quarterly) Benchmarks
| Nevro Corp | 10.58M |
| Inspire Medical Systems Inc | 26.08M |
| TransMedics Group Inc | 14.27M |
| Electromed Inc | 0.166M |
| Myomo Inc | 1.249M |